Sixty two percent of this specific drug class received the FDA’s most stringent warning, known as a “black box.” Most of the serious adverse effects were identified only after the drugs were on the market.

 “It raises the question of should we be regulating them differently,” said Joseph Ross, an associate professor of medicine at Yale School of Medicine, who has studied drug safety. Read the full article here.